Nicholas J Slipek

7PUBLICATIONS
27CO-AUTHORS
Molecular targetsGene and molecular therapyRegenerative medicine (incl. stem cells)Reaction engineering (excl. nuclear reactions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 18, 2024
Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base Editing.

Minjing Wang, Joshua B Krueger, Alexandria K Gilkey

|Dec 13, 2023
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair.

Beau R Webber, Matthew J Johnson, Joseph G Skeate

|Sep 09, 2022
A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes.

Kanut Laoharawee, Matthew J Johnson, Walker S Lahr

|Apr 24, 2021
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells.

Mitchell G Kluesner, Walker S Lahr, Cara-Lin Lonetree

|Oct 01, 2020
Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic Osteosarcoma.

Branden A Smeester, Garrett M Draper, Nicholas J Slipek

|Dec 08, 2019
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors.

Beau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner

Pageof 2

Frequent Collaborators

6 joint publications

Beau R Webber

5 joint publications

Emily J Pomeroy

4 joint publications

Mitchell G Kluesner

3 joint publications

Matthew J Johnson